5M0B Stock Overview
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally.
| Snowflake Score | |
|---|---|
| Valuation | 3/6 |
| Future Growth | 4/6 |
| Past Performance | 4/6 |
| Financial Health | 1/6 |
| Dividends | 1/6 |
Rewards
Risk Analysis
Medicover AB (publ) Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | kr11.36 |
| 52 Week High | kr16.40 |
| 52 Week Low | kr9.99 |
| Beta | 1.51 |
| 1 Month Change | -2.82% |
| 3 Month Change | -22.98% |
| 1 Year Change | -24.47% |
| 3 Year Change | -50.82% |
| 5 Year Change | 49.08% |
| Change since IPO | 74.42% |
Recent News & Updates
Recent updates
Shareholder Returns
| 5M0B | DE Healthcare | DE Market | |
|---|---|---|---|
| 7D | 1.8% | 2.7% | 0.5% |
| 1Y | -24.5% | -1.8% | 1.3% |
Return vs Industry: 5M0B underperformed the German Healthcare industry which returned 0.6% over the past year.
Return vs Market: 5M0B underperformed the German Market which returned 2.3% over the past year.
Price Volatility
| 5M0B volatility | |
|---|---|
| 5M0B Average Weekly Movement | 4.9% |
| Healthcare Industry Average Movement | 6.1% |
| Market Average Movement | 4.8% |
| 10% most volatile stocks in DE Market | 10.2% |
| 10% least volatile stocks in DE Market | 2.4% |
Stable Share Price: 5M0B's share price has been volatile over the past 3 months.
Volatility Over Time: 5M0B's weekly volatility (5%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1995 | 45,316 | Fredrik Rågmark | www.medicover.com |
Medicover AB (publ) provides healthcare and diagnostic services in Poland, Sweden, and internationally. The company’s Healthcare services includes service outpatient and inpatient care; dental services; other services, including non-medical related services, such as sports memberships, benefit cards, and optics, as well as wellness services; hospital care; and preventive care. Its Diagnostic services comprise various tests, including allergy and autoimmune diagnostics, bacteriology, parasitology, biochemistry and immunochemistry, blood group diagnostics/transfusion medicine, tumour markers, clinical chemistry, cytology, haematology, histopathology, human genetics, hygiene, immunology and immunochemistry, infectious diseases, microbiology, molecular biology, and pharmacology/toxicology.
Medicover AB (publ) Fundamentals Summary
| 5M0B fundamental statistics | |
|---|---|
| Market cap | €1.67b |
| Earnings (TTM) | €17.60m |
| Revenue (TTM) | €1.75b |
95.1x
P/E Ratio1.0x
P/S RatioIs 5M0B overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 5M0B income statement (TTM) | |
|---|---|
| Revenue | €1.75b |
| Cost of Revenue | €1.39b |
| Gross Profit | €359.40m |
| Other Expenses | €341.80m |
| Earnings | €17.60m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
Apr 26, 2024
| Earnings per share (EPS) | 0.12 |
| Gross Margin | 20.58% |
| Net Profit Margin | 1.01% |
| Debt/Equity Ratio | 106.9% |
How did 5M0B perform over the long term?
See historical performance and comparisonDividends
1.1%
Current Dividend Yield102%
Payout RatioDoes 5M0B pay a reliable dividends?
See 5M0B dividend history and benchmarks| Medicover dividend dates | |
|---|---|
| Ex Dividend Date | Apr 29 2024 |
| Dividend Pay Date | May 06 2024 |
| Days until Ex dividend | 3 days |
| Days until Dividend pay date | 10 days |
Does 5M0B pay a reliable dividends?
See 5M0B dividend history and benchmarks